Drug intelligence / Profile preview

LuraLean Cardio

Development stage
Unknown
Lead developer
AHD International
Modality
Small Molecules
Administration
Oral
01

Overview

LuraLean Cardio is a combination dietary supplement formulated to support cardiovascular health by managing cholesterol levels and body weight. It consists of LuraLean, a proprietary, highly purified, high-molecular-weight glucomannan fiber derived from the konjac root (*Amorphophallus konjac*), and red yeast rice extract. Glucomannan is a soluble fiber that promotes satiety and reduces the intestinal absorption of dietary fats and cholesterol by increasing gastric viscosity and sequestering bile acids. Red yeast rice extract contains monacolins, specifically monacolin K, which is chemically identical to lovastatin and acts as a competitive inhibitor of HMG-CoA reductase, the rate-limiting enzyme in endogenous cholesterol synthesis. This dual-action approach targets both the exogenous absorption and endogenous production of cholesterol.

Brand names
LuraLean Cardio
Other names
LuraLean Cardioglucomannan + red yeast rice
02

Targets

HMGCR (3-hydroxy-3-methylglutaryl-coenzyme A reductase)

Beyond the preview

Go deeper on LuraLean Cardio.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on LuraLean Cardio.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call